Surrozen (SRZN) announces a $60 million public offering of 1.89 million shares at $31.67 each, with Morgan Stanley and Guggenheim leading the transaction. (158 chars)
Surrozen (SRZN) closes a $95.1 million private placement tranche after FDA clearance of its SZN-8141 IND application, extending its cash runway into 2029.
Surrozen (SRZN) to receive $95.1 million in gross proceeds following FDA clearance of the SZN-8141 IND, triggering the second closing of a private placement.
Surrozen, Inc./DE · · 3 min read
Track Surrozen, Inc./DE live
Get the next Surrozen, Inc./DE SEC filing seconds after it lands.